The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
Source: https://www.cnbc.com/2024/05/31/fda-app ... niors.html
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
